Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Related Citations for PubMed (Select 20516367)

1.

Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.

White TA, Johnson T, Zarzhevsky N, Tom C, Delacroix S, Holroyd EW, Maroney SA, Singh R, Pan S, Fay WP, van Deursen J, Mast AE, Sandhu GS, Simari RD.

Blood. 2010 Sep 9;116(10):1787-94. doi: 10.1182/blood-2009-10-250910. Epub 2010 Jun 1.

2.
3.

Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

Huang ZF, Higuchi D, Lasky N, Broze GJ Jr.

Blood. 1997 Aug 1;90(3):944-51.

4.

A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.

Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N.

Blood. 2005 Apr 1;105(7):2777-82. Epub 2004 Dec 14.

5.

Structure and biology of tissue factor pathway inhibitor.

Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP.

Thromb Haemost. 2001 Oct;86(4):959-72. Review.

PMID:
11686353
6.

Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.

Nadir Y, Brenner B, Gingis-Velitski S, Levy-Adam F, Ilan N, Zcharia E, Nadir E, Vlodavsky I.

Thromb Haemost. 2008 Jan;99(1):133-41.

PMID:
18217145
7.

Tissue factor pathway inhibitor gene disruption.

Broze GJ Jr.

Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S89-92. Review.

PMID:
9819035
8.
9.

Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.

Westrick RJ, Bodary PF, Xu Z, Shen YC, Broze GJ, Eitzman DT.

Circulation. 2001 Jun 26;103(25):3044-6.

10.

Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor.

White TA, Pan S, Witt TA, Simari RD.

Thromb Res. 2010 Jan;125(1):84-9. doi: 10.1016/j.thromres.2009.03.006. Epub 2009 Apr 26.

12.

Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.

Harris GM, Stendt CL, Vollenhoven BJ, Gan TE, Tipping PG.

Am J Hematol. 1999 Mar;60(3):175-80.

PMID:
10072106
13.

Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling.

Singh R, Pan S, Mueske CS, Witt TA, Kleppe LS, Peterson TE, Caplice NM, Simari RD.

Thromb Haemost. 2003 Apr;89(4):747-51.

PMID:
12669131
14.

Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.

Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ.

Hypertension. 2009 Sep;54(3):537-43. doi: 10.1161/HYPERTENSIONAHA.109.131110. Epub 2009 Jul 27.

15.

Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain.

Schuepbach RA, Velez K, Riewald M.

Blood. 2011 Jun 9;117(23):6338-46. doi: 10.1182/blood-2010-10-316257. Epub 2011 Apr 7.

16.

Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.

Piro O, Broze GJ Jr.

Circulation. 2004 Dec 7;110(23):3567-72. Epub 2004 Nov 22.

17.

Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

Hackeng TM, Seré KM, Tans G, Rosing J.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3106-11. Epub 2006 Feb 17.

18.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk